Epidon

Epidon is a generic formulation of the anthracycline chemotherapy agent epirubicin, manufactured and marketed by Odon Lifescience. As an antineoplastic antibiotic, it is primarily utilized in the treatment of various malignancies, including breast cancer, gastric cancer, and lymphomas. The drug's mechanism of action involves intercalating between DNA base pairs and inhibiting the enzyme DNA topoisomerase II, which leads to the inhibition of DNA synthesis and the induction of apoptosis in rapidly dividing cancer cells. It is typically administered intravenously and is part of Odon Lifescience's extensive portfolio of approved generic oncology products.

Brand names

Epidon

Other names

epirubicin